Novel Role of Phosphatidylinositol 3-Kinase in CD28-mediated Costimulation

Ligation of the CD28 surface receptor provides a major costimulatory signal for full scale T cell activation. Despite extensive studies, the intracellular signaling pathways delivered by CD28 ligation are not fully understood. A particularly controversial matter is the role of phosphatidylinositol 3...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of biological chemistry 2001-03, Vol.276 (12), p.9003-9008
Hauptverfasser: Harada, Yohsuke, Tanabe, Eri, Watanabe, Ryosuke, Weiss, Bonnie D., Matsumoto, Akira, Ariga, Hiroyoshi, Koiwai, Osamu, Fukui, Yasuhisa, Kubo, Masato, June, Carl H., Abe, Ryo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 9008
container_issue 12
container_start_page 9003
container_title The Journal of biological chemistry
container_volume 276
creator Harada, Yohsuke
Tanabe, Eri
Watanabe, Ryosuke
Weiss, Bonnie D.
Matsumoto, Akira
Ariga, Hiroyoshi
Koiwai, Osamu
Fukui, Yasuhisa
Kubo, Masato
June, Carl H.
Abe, Ryo
description Ligation of the CD28 surface receptor provides a major costimulatory signal for full scale T cell activation. Despite extensive studies, the intracellular signaling pathways delivered by CD28 ligation are not fully understood. A particularly controversial matter is the role of phosphatidylinositol 3-kinase (PI3K) in CD28-mediated costimulation. It is known that the binding site for PI3K and Grb-2 lies nested within the YMNM motif of the CD28 cytoplasmic domain. To elucidate the role of PI3K during CD28-mediated interleukin-2 (IL-2) production, CD28 YMNM point and deletion mutants were expressed in Jurkat cells. We then measured IL-2 promoter activation after CD28 ligation. Our results showed that the Y189F mutant, which disrupts binding by PI3K, and the YMNM deletion mutant both demonstrated reduced but significant activity for IL-2 promoter activation. In contrast, the N191A mutant, which retains PI3K binding ability, resulted in a complete abrogation of activity, suggesting that PI3K mediates a negative effect upon transcriptional activation of theIL-2 gene. Consistent with this idea, we found that the addition of a PI3K pharmacological inhibitor augmented IL-2 promoter activity, whereas coexpression of a constitutively active form of PI3K reduced this activity. Taken together, these data indicate that PI3K, when associated with the YMNM motif, may act as a negative mediator in CD28-mediated IL-2 gene transcription.
doi_str_mv 10.1074/jbc.M005051200
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_76983386</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0021925819461966</els_id><sourcerecordid>76983386</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-6db9f565f22a73972aea6046c5f9561b524c631ce336681b7e092108f641f6ff3</originalsourceid><addsrcrecordid>eNp1kMtLxDAQh4Mo7vq4epSC4K1rHk3aHmV9uz4QBW8hTSc2S9usTbuy_72RXdiTw8Bcvvkx8yF0QvCE4DS5mBd68oQxx5xQjHfQmOCMxYyTz100xpiSOKc8G6ED7-c4VJKTfTQioVjoMXp4dkuoozdXQ-RM9Fo5v6hUb8tVbVvnbe_qiMWPtlUeIttG0yuaxQ2UVvVQRlPne9sMdVhw7RHaM6r2cLyZh-jj5vp9ehfPXm7vp5ezWCdp0seiLHLDBTeUqpTlKVWgBE6E5ibnghScJlowooExITJSpIBzGr4yIiFGGMMO0fk6d9G57wF8LxvrNdS1asENXqYizxjLRAAna1B3zvsOjFx0tlHdShIs_-zJYE9u7YWF003yUIQft_hGVwDO1kBlv6of24EsrNMVNJKmQhIq85ASqGxNQbCwtNBJry20OljrQPeydPa_C34BepmHaw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>76983386</pqid></control><display><type>article</type><title>Novel Role of Phosphatidylinositol 3-Kinase in CD28-mediated Costimulation</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Harada, Yohsuke ; Tanabe, Eri ; Watanabe, Ryosuke ; Weiss, Bonnie D. ; Matsumoto, Akira ; Ariga, Hiroyoshi ; Koiwai, Osamu ; Fukui, Yasuhisa ; Kubo, Masato ; June, Carl H. ; Abe, Ryo</creator><creatorcontrib>Harada, Yohsuke ; Tanabe, Eri ; Watanabe, Ryosuke ; Weiss, Bonnie D. ; Matsumoto, Akira ; Ariga, Hiroyoshi ; Koiwai, Osamu ; Fukui, Yasuhisa ; Kubo, Masato ; June, Carl H. ; Abe, Ryo</creatorcontrib><description>Ligation of the CD28 surface receptor provides a major costimulatory signal for full scale T cell activation. Despite extensive studies, the intracellular signaling pathways delivered by CD28 ligation are not fully understood. A particularly controversial matter is the role of phosphatidylinositol 3-kinase (PI3K) in CD28-mediated costimulation. It is known that the binding site for PI3K and Grb-2 lies nested within the YMNM motif of the CD28 cytoplasmic domain. To elucidate the role of PI3K during CD28-mediated interleukin-2 (IL-2) production, CD28 YMNM point and deletion mutants were expressed in Jurkat cells. We then measured IL-2 promoter activation after CD28 ligation. Our results showed that the Y189F mutant, which disrupts binding by PI3K, and the YMNM deletion mutant both demonstrated reduced but significant activity for IL-2 promoter activation. In contrast, the N191A mutant, which retains PI3K binding ability, resulted in a complete abrogation of activity, suggesting that PI3K mediates a negative effect upon transcriptional activation of theIL-2 gene. Consistent with this idea, we found that the addition of a PI3K pharmacological inhibitor augmented IL-2 promoter activity, whereas coexpression of a constitutively active form of PI3K reduced this activity. Taken together, these data indicate that PI3K, when associated with the YMNM motif, may act as a negative mediator in CD28-mediated IL-2 gene transcription.</description><identifier>ISSN: 0021-9258</identifier><identifier>EISSN: 1083-351X</identifier><identifier>DOI: 10.1074/jbc.M005051200</identifier><identifier>PMID: 11113113</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Amino Acid Motifs ; Amino Acid Sequence ; CD28 Antigens - chemistry ; CD28 Antigens - physiology ; Chromones - pharmacology ; Enzyme Inhibitors - pharmacology ; Gene Expression Regulation ; Humans ; Interleukin-2 - genetics ; Jurkat Cells ; Lymphocyte Activation - physiology ; Molecular Sequence Data ; Morpholines - pharmacology ; Phosphatidylinositol 3-Kinases - physiology ; Phosphoinositide-3 Kinase Inhibitors ; Promoter Regions, Genetic ; Sequence Homology, Amino Acid ; T-Lymphocytes - immunology</subject><ispartof>The Journal of biological chemistry, 2001-03, Vol.276 (12), p.9003-9008</ispartof><rights>2001 © 2001 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-6db9f565f22a73972aea6046c5f9561b524c631ce336681b7e092108f641f6ff3</citedby><cites>FETCH-LOGICAL-c474t-6db9f565f22a73972aea6046c5f9561b524c631ce336681b7e092108f641f6ff3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11113113$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Harada, Yohsuke</creatorcontrib><creatorcontrib>Tanabe, Eri</creatorcontrib><creatorcontrib>Watanabe, Ryosuke</creatorcontrib><creatorcontrib>Weiss, Bonnie D.</creatorcontrib><creatorcontrib>Matsumoto, Akira</creatorcontrib><creatorcontrib>Ariga, Hiroyoshi</creatorcontrib><creatorcontrib>Koiwai, Osamu</creatorcontrib><creatorcontrib>Fukui, Yasuhisa</creatorcontrib><creatorcontrib>Kubo, Masato</creatorcontrib><creatorcontrib>June, Carl H.</creatorcontrib><creatorcontrib>Abe, Ryo</creatorcontrib><title>Novel Role of Phosphatidylinositol 3-Kinase in CD28-mediated Costimulation</title><title>The Journal of biological chemistry</title><addtitle>J Biol Chem</addtitle><description>Ligation of the CD28 surface receptor provides a major costimulatory signal for full scale T cell activation. Despite extensive studies, the intracellular signaling pathways delivered by CD28 ligation are not fully understood. A particularly controversial matter is the role of phosphatidylinositol 3-kinase (PI3K) in CD28-mediated costimulation. It is known that the binding site for PI3K and Grb-2 lies nested within the YMNM motif of the CD28 cytoplasmic domain. To elucidate the role of PI3K during CD28-mediated interleukin-2 (IL-2) production, CD28 YMNM point and deletion mutants were expressed in Jurkat cells. We then measured IL-2 promoter activation after CD28 ligation. Our results showed that the Y189F mutant, which disrupts binding by PI3K, and the YMNM deletion mutant both demonstrated reduced but significant activity for IL-2 promoter activation. In contrast, the N191A mutant, which retains PI3K binding ability, resulted in a complete abrogation of activity, suggesting that PI3K mediates a negative effect upon transcriptional activation of theIL-2 gene. Consistent with this idea, we found that the addition of a PI3K pharmacological inhibitor augmented IL-2 promoter activity, whereas coexpression of a constitutively active form of PI3K reduced this activity. Taken together, these data indicate that PI3K, when associated with the YMNM motif, may act as a negative mediator in CD28-mediated IL-2 gene transcription.</description><subject>Amino Acid Motifs</subject><subject>Amino Acid Sequence</subject><subject>CD28 Antigens - chemistry</subject><subject>CD28 Antigens - physiology</subject><subject>Chromones - pharmacology</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Gene Expression Regulation</subject><subject>Humans</subject><subject>Interleukin-2 - genetics</subject><subject>Jurkat Cells</subject><subject>Lymphocyte Activation - physiology</subject><subject>Molecular Sequence Data</subject><subject>Morpholines - pharmacology</subject><subject>Phosphatidylinositol 3-Kinases - physiology</subject><subject>Phosphoinositide-3 Kinase Inhibitors</subject><subject>Promoter Regions, Genetic</subject><subject>Sequence Homology, Amino Acid</subject><subject>T-Lymphocytes - immunology</subject><issn>0021-9258</issn><issn>1083-351X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kMtLxDAQh4Mo7vq4epSC4K1rHk3aHmV9uz4QBW8hTSc2S9usTbuy_72RXdiTw8Bcvvkx8yF0QvCE4DS5mBd68oQxx5xQjHfQmOCMxYyTz100xpiSOKc8G6ED7-c4VJKTfTQioVjoMXp4dkuoozdXQ-RM9Fo5v6hUb8tVbVvnbe_qiMWPtlUeIttG0yuaxQ2UVvVQRlPne9sMdVhw7RHaM6r2cLyZh-jj5vp9ehfPXm7vp5ezWCdp0seiLHLDBTeUqpTlKVWgBE6E5ibnghScJlowooExITJSpIBzGr4yIiFGGMMO0fk6d9G57wF8LxvrNdS1asENXqYizxjLRAAna1B3zvsOjFx0tlHdShIs_-zJYE9u7YWF003yUIQft_hGVwDO1kBlv6of24EsrNMVNJKmQhIq85ASqGxNQbCwtNBJry20OljrQPeydPa_C34BepmHaw</recordid><startdate>20010323</startdate><enddate>20010323</enddate><creator>Harada, Yohsuke</creator><creator>Tanabe, Eri</creator><creator>Watanabe, Ryosuke</creator><creator>Weiss, Bonnie D.</creator><creator>Matsumoto, Akira</creator><creator>Ariga, Hiroyoshi</creator><creator>Koiwai, Osamu</creator><creator>Fukui, Yasuhisa</creator><creator>Kubo, Masato</creator><creator>June, Carl H.</creator><creator>Abe, Ryo</creator><general>Elsevier Inc</general><general>American Society for Biochemistry and Molecular Biology</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20010323</creationdate><title>Novel Role of Phosphatidylinositol 3-Kinase in CD28-mediated Costimulation</title><author>Harada, Yohsuke ; Tanabe, Eri ; Watanabe, Ryosuke ; Weiss, Bonnie D. ; Matsumoto, Akira ; Ariga, Hiroyoshi ; Koiwai, Osamu ; Fukui, Yasuhisa ; Kubo, Masato ; June, Carl H. ; Abe, Ryo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-6db9f565f22a73972aea6046c5f9561b524c631ce336681b7e092108f641f6ff3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Amino Acid Motifs</topic><topic>Amino Acid Sequence</topic><topic>CD28 Antigens - chemistry</topic><topic>CD28 Antigens - physiology</topic><topic>Chromones - pharmacology</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Gene Expression Regulation</topic><topic>Humans</topic><topic>Interleukin-2 - genetics</topic><topic>Jurkat Cells</topic><topic>Lymphocyte Activation - physiology</topic><topic>Molecular Sequence Data</topic><topic>Morpholines - pharmacology</topic><topic>Phosphatidylinositol 3-Kinases - physiology</topic><topic>Phosphoinositide-3 Kinase Inhibitors</topic><topic>Promoter Regions, Genetic</topic><topic>Sequence Homology, Amino Acid</topic><topic>T-Lymphocytes - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Harada, Yohsuke</creatorcontrib><creatorcontrib>Tanabe, Eri</creatorcontrib><creatorcontrib>Watanabe, Ryosuke</creatorcontrib><creatorcontrib>Weiss, Bonnie D.</creatorcontrib><creatorcontrib>Matsumoto, Akira</creatorcontrib><creatorcontrib>Ariga, Hiroyoshi</creatorcontrib><creatorcontrib>Koiwai, Osamu</creatorcontrib><creatorcontrib>Fukui, Yasuhisa</creatorcontrib><creatorcontrib>Kubo, Masato</creatorcontrib><creatorcontrib>June, Carl H.</creatorcontrib><creatorcontrib>Abe, Ryo</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of biological chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Harada, Yohsuke</au><au>Tanabe, Eri</au><au>Watanabe, Ryosuke</au><au>Weiss, Bonnie D.</au><au>Matsumoto, Akira</au><au>Ariga, Hiroyoshi</au><au>Koiwai, Osamu</au><au>Fukui, Yasuhisa</au><au>Kubo, Masato</au><au>June, Carl H.</au><au>Abe, Ryo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Novel Role of Phosphatidylinositol 3-Kinase in CD28-mediated Costimulation</atitle><jtitle>The Journal of biological chemistry</jtitle><addtitle>J Biol Chem</addtitle><date>2001-03-23</date><risdate>2001</risdate><volume>276</volume><issue>12</issue><spage>9003</spage><epage>9008</epage><pages>9003-9008</pages><issn>0021-9258</issn><eissn>1083-351X</eissn><abstract>Ligation of the CD28 surface receptor provides a major costimulatory signal for full scale T cell activation. Despite extensive studies, the intracellular signaling pathways delivered by CD28 ligation are not fully understood. A particularly controversial matter is the role of phosphatidylinositol 3-kinase (PI3K) in CD28-mediated costimulation. It is known that the binding site for PI3K and Grb-2 lies nested within the YMNM motif of the CD28 cytoplasmic domain. To elucidate the role of PI3K during CD28-mediated interleukin-2 (IL-2) production, CD28 YMNM point and deletion mutants were expressed in Jurkat cells. We then measured IL-2 promoter activation after CD28 ligation. Our results showed that the Y189F mutant, which disrupts binding by PI3K, and the YMNM deletion mutant both demonstrated reduced but significant activity for IL-2 promoter activation. In contrast, the N191A mutant, which retains PI3K binding ability, resulted in a complete abrogation of activity, suggesting that PI3K mediates a negative effect upon transcriptional activation of theIL-2 gene. Consistent with this idea, we found that the addition of a PI3K pharmacological inhibitor augmented IL-2 promoter activity, whereas coexpression of a constitutively active form of PI3K reduced this activity. Taken together, these data indicate that PI3K, when associated with the YMNM motif, may act as a negative mediator in CD28-mediated IL-2 gene transcription.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>11113113</pmid><doi>10.1074/jbc.M005051200</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-9258
ispartof The Journal of biological chemistry, 2001-03, Vol.276 (12), p.9003-9008
issn 0021-9258
1083-351X
language eng
recordid cdi_proquest_miscellaneous_76983386
source MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Amino Acid Motifs
Amino Acid Sequence
CD28 Antigens - chemistry
CD28 Antigens - physiology
Chromones - pharmacology
Enzyme Inhibitors - pharmacology
Gene Expression Regulation
Humans
Interleukin-2 - genetics
Jurkat Cells
Lymphocyte Activation - physiology
Molecular Sequence Data
Morpholines - pharmacology
Phosphatidylinositol 3-Kinases - physiology
Phosphoinositide-3 Kinase Inhibitors
Promoter Regions, Genetic
Sequence Homology, Amino Acid
T-Lymphocytes - immunology
title Novel Role of Phosphatidylinositol 3-Kinase in CD28-mediated Costimulation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T10%3A39%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Novel%20Role%20of%20Phosphatidylinositol%203-Kinase%20in%20CD28-mediated%20Costimulation&rft.jtitle=The%20Journal%20of%20biological%20chemistry&rft.au=Harada,%20Yohsuke&rft.date=2001-03-23&rft.volume=276&rft.issue=12&rft.spage=9003&rft.epage=9008&rft.pages=9003-9008&rft.issn=0021-9258&rft.eissn=1083-351X&rft_id=info:doi/10.1074/jbc.M005051200&rft_dat=%3Cproquest_cross%3E76983386%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=76983386&rft_id=info:pmid/11113113&rft_els_id=S0021925819461966&rfr_iscdi=true